Company profile
Ever Fortune.Ai, Co., Ltd.
Ever Fortune.Ai, Co., Ltd. has 10 AI-enabled medical devices on the FDA list. The first decision was on April 28, 2022 and the most recent on April 22, 2026 (EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100)). Its most common review panel is Radiology (10 devices).
10AI devices
2022First decision
2026Latest decision
1Specialties
Per year
20222023202420252026
By specialty
Related guides
Timeline
- EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100) · Radiology · QAS
- Seg Pro V3 (RT-300) · Radiology · QKB
- EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) · Radiology · QAS
- EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100) · Radiology · QAS
- EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) · Radiology · QIH
- EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM · Radiology · QAS
- EFAI NeuroSuite CT ICH Assessment System · Radiology · QAS
- EFAI RTSUITE CT HCAP-Segmentation System · Radiology · QKB
- EFAI ChestSuite XR Pleural Effusion Assessment System · Radiology · QFM
- EFAI RTSuite CT HN-Segmentation System · Radiology · QKB